β-Thalassemias are a group of hereditary blood disorders characterized by abnormalities in the synthesis of the β hemoglobin (Hb) chains. This disease causes excessive storage of iron in all organs and endocrine glands. Treatment of β-thalassemia major (β-TM) consists of regular blood transfusions, iron chelation and management of secondary complications of iron overload. Endocrine abnormalities are frequently observed. In the last 25 years, the clinical picture of the disease has changed progressively thanks to improvement of treatments. Today, the majority of thalassemic patients reach adult age. The better prognosis and the longer lifespan of affected patients could be responsible for the susceptibility to other concomitant diseases which can manifest during their life. In this context, the possibility and recent literature reports about some cases of malignancy in thalassemic patients open new scenarios for oncoming years. We describe first reports of endocrine malignancies in thalassemic patients. © 2011 Informa Healthcare USA, Inc.

Malignancies in β-thalassemia patients: first description of two cases of thyroid cancer and review of the literature / Maurizio, Poggi; Francesco, Sorrentino; Pascucci, Chiara; Salvatore, Monti; Lauri, Chiara; Valeria, Bisogni; Toscano, Vincenzo; Paolo, Cianciulli. - In: HEMOGLOBIN. - ISSN 0363-0269. - STAMPA. - 35:4(2011), pp. 439-446. [10.3109/03630269.2011.588355]

Malignancies in β-thalassemia patients: first description of two cases of thyroid cancer and review of the literature.

PASCUCCI, CHIARA;Chiara Lauri;TOSCANO, Vincenzo;
2011

Abstract

β-Thalassemias are a group of hereditary blood disorders characterized by abnormalities in the synthesis of the β hemoglobin (Hb) chains. This disease causes excessive storage of iron in all organs and endocrine glands. Treatment of β-thalassemia major (β-TM) consists of regular blood transfusions, iron chelation and management of secondary complications of iron overload. Endocrine abnormalities are frequently observed. In the last 25 years, the clinical picture of the disease has changed progressively thanks to improvement of treatments. Today, the majority of thalassemic patients reach adult age. The better prognosis and the longer lifespan of affected patients could be responsible for the susceptibility to other concomitant diseases which can manifest during their life. In this context, the possibility and recent literature reports about some cases of malignancy in thalassemic patients open new scenarios for oncoming years. We describe first reports of endocrine malignancies in thalassemic patients. © 2011 Informa Healthcare USA, Inc.
2011
endocrine neoplasia; thyroid cancer; thalassemia; iron
01 Pubblicazione su rivista::01a Articolo in rivista
Malignancies in β-thalassemia patients: first description of two cases of thyroid cancer and review of the literature / Maurizio, Poggi; Francesco, Sorrentino; Pascucci, Chiara; Salvatore, Monti; Lauri, Chiara; Valeria, Bisogni; Toscano, Vincenzo; Paolo, Cianciulli. - In: HEMOGLOBIN. - ISSN 0363-0269. - STAMPA. - 35:4(2011), pp. 439-446. [10.3109/03630269.2011.588355]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/437743
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 20
social impact